Amazon and PillPack today announced that they have entered into a definitive merger agreement under which Amazon will acquire PillPack. PillPack is a pharmacy said to be designed to provide the best possible customer experience in the U.S. for people who take multiple daily prescriptions.
Walgreens Boots Alliance (WBA), which entered the Dow this week, topped analysts’s forecasts in its third quarter earnings, boosted its dividend and announced a $10 billion share buyback.
Walgreens Boots Alliance announced that its board of directors has authorized a share repurchase program for up to $10 billion of the company’s shares. The program has no specified expiration date.
Avella has announced that it will distribute Braftovi (encorafenib and Mektovi (binimetinib), a combination therapy recently FDA approved for patients for the treatment of patients with unresectable or metastatic melanoma.
In order to apply sunscreen to hard to reach areas such as the back, neck, shoulders, sides, hips, legs and feet, Starco Brands introduces Honu, the first and only sunscreen with a patented spray wand.
Publix has once again been recognized by Fortune Magazine as one of the Best Workplaces for Millennials. Millennials, those born between 1981 and 1998, make up about 45 percent of Publix’s workforce.
Faced with the ever-increasing consumer demand for engaging experiences, the beauty retailing landscape is forced to undergo revolutionary changes. Retailers and beauty brands are adapting to these changes by offering new compelling shopping experiences and utilizing technology online and offline.
Aurobindo Pharma has launched atazanavir capsules 100 mg, 150 mg, 200 mg and 300 mg upon receiving final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application.
Ahead of the August 9 shareholders vote on the proposed merger with Albertsons, Rite Aid Corp. reported operating results for its first fiscal quarter ended June 2, 2018. For the first quarter, the company reported net loss from continuing operations of $41.7 million, or $0.
Albertsons Cos. announced that more than 1,600 of its pharmacies across 21 states have pharmacists with the ability to independently provide naloxone, a medication used to reverse the impacts of an opioid overdose, and to educate patients and caregivers about its use.
Soleo Health, an innovative leader in specialty infusion services, announced the company has been selected by Genentech (member of the Roche Group), a world-leading biotechnology company with multiple products on the market and a strong development pipeline, to dispense two limited distribution drug
Rite Aid Corp. announced that starting Sunday, July 1, Rite Aid pharmacists at all locations in Idaho will be able to prescribe medications to treat select, common conditions, under the Pharmacist Prescriptive Authority Rule Docket 27-0104-1701 promulgated by the Idaho State Board of Pharmacy.
Kimberly-Clark Corp. has reported its progress toward achieving its Sustainability 2022 strategy to create social, environmental and business value.
HeadBlade, a leader in HeadCare and developers of the ultimate head shaving razor, the HeadBlade MOTO, announced Tom Wainman, formerly a pitchman for Hair Club for Men, as its new spokesperson.
AcneFree announces its support of the American Acne and Rosacea Society (AARS), a non-profit organization, as a part of its commitment to better educate the 21 million teenagers in the U.S. – approximately 80% of all teens – who suffer from acne and occasional breakouts.
Upsher-Smith Laboratories (Upsher-Smith) announced that it will be featuring Platinum Pass, the latest addition to the Access Pathways Program for Qudexy XR (topiramate) extended-release capsules at the 60th Annual Scientific Meeting of the American Headache Society (AHS), June 28 to July 1, in
